eIF5A1 Inhibitors are a specialized class of chemical compounds that target and inhibit the activity of eukaryotic initiation factor 5A1 (eIF5A1), a highly conserved protein involved in the regulation of translation. eIF5A1 is unique because it is the only known protein to undergo post-translational modification by hypusination, a process that is crucial for its function in promoting the synthesis of specific proteins, particularly those involved in cell proliferation, differentiation, and stress responses. By inhibiting eIF5A1, researchers can study the detailed mechanisms of translation elongation and the role of hypusinated eIF5A1 in various cellular processes, including the synthesis of proteins that are otherwise challenging to produce or regulate within the cell.
The inhibition of eIF5A1 is particularly valuable for exploring its involvement in the regulation of proteins with proline-rich sequences, which are known to be critical for the control of cell cycle progression and apoptosis. eIF5A1 Inhibitors provide a powerful tool for dissecting the molecular pathways that rely on these specific proteins, allowing scientists to gain insights into how cells regulate essential functions like growth, division, and response to environmental stressors. Furthermore, these inhibitors offer a way to study the broader impact of translation control on cellular homeostasis and the maintenance of protein quality. By modulating eIF5A1 activity, researchers can explore how the balance of protein synthesis and degradation is maintained in the cell and how disruptions to this balance can lead to various cellular outcomes. Overall, eIF5A1 Inhibitors serve as a critical resource for advancing our understanding of the complex network of interactions that govern translation and protein synthesis in eukaryotic cells.
SEE ALSO...
Items 11 to 18 of 18 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
DNA damage from Doxorubicin may cause the cell to prioritize DNA repair over regular functions, potentially suppressing RNAi machinery and decreasing eIF2C2 levels. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin′s inhibition of topoisomerase I can cause DNA damage, which might lead to a reduced focus on RNAi processes and subsequent lower eIF2C2 expression. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
By inhibiting Hsp90, Geldanamycin may destabilize proteins associated with RNAi, which could include a decrease in eIF2C2 stability or synthesis. | ||||||
MLN7243 | 1450833-55-2 | sc-507338 | 5 mg | $340.00 | ||
TAK-243 is a small molecule inhibitor of ubiquitin-activating enzyme (UAE) that indirectly affects EIF3ε by inhibiting protein translation. It has been studied for its potential as an anti-cancer therapy. | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
A natural compound isolated from the plant Aglaia foveolata, known for its potent inhibition of EIF4AI. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
Another natural compound found in several plants, such as the Aglaia genus, with strong EIF4AI inhibitory activity. | ||||||
4E1RCat | 328998-25-0 | sc-361085 sc-361085A | 10 mg 50 mg | $189.00 $797.00 | ||
A synthetic EIF4AI inhibitor designed to disrupt the eIF4F complex, thereby inhibiting cap-dependent translation. | ||||||
eIF4E/eIF4G Interaction Inhibitor, 4EGI-1 | 315706-13-9 | sc-202597 | 10 mg | $260.00 | 14 | |
A small molecule that disrupts the eIF4E-eIF4G interaction, thereby preventing translation initiation. | ||||||